Gut microbiome stool test

For the detection and assessment of the intestinal microbiome of the intestine

The intestinal microbiome is the term used to describe the totality of all microorganisms that colonise the intestine. A balanced ratio of intestinal bacteria is essential for human health. This is because, as numerous studies have shown, an imbalance in the intestinal microbiome is associated with various diseases. These include metabolic syndrome, diabetes, inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, irritable bowel syndrome, bowel cancer, calcium oxalate urinary stones, cardiovascular diseases, rheumatoid arthritis and neurological disorders.

So far, the so-called next-generation sequencing method has only been used in a scientific context to detect imbalances in the intestinal flora. In contrast to conventional stool diagnostics, it not only covers a limited range of intestinal germs, but also the molecular genetic analysis of the entire bacterial intestinal microbiome. In addition, the effects of the individual highly complex microbiota on colonisation resistance, digestive processes, absorption of nutrients and vitamins as well as on immunity can be assessed more precisely.

The analysis even detects anaerobic bacteria that cannot be cultured. The standard of microbiological stool diagnostics in the 20th century was mainly based on a cultural system, on nutrient media and subsequent enzymatic differentiation. However, the cultural methods grow very few of the anaerobic bacteria (approx. 99 % of the intestinal bacteria). In recent years, there has been a rapid development of examination methods. Nowadays, in modern laboratories, the identification of bacteria from the plant on culture media is mostly done by mass spectrometry (MALDI-TOF = Matrix Assisted Laser Desorption Ionization-Time of Flight) or directly from the submitted material by molecular biological methods (PCR = Polymerase Chain Reaction). The disadvantage, however, is that PCR is a very selective and cost-intensive technology.

In the future, the microbiome data and its expertise can be updated and expanded at regular intervals so that new findings are reflected in the findings.

The molecular genetic analysis includes the

• Analysis of the species diversity of the intestinal microbiome (diversity)
• Statement on bacterial dysbiosis
• Determination of the enterotype
• Frequency distribution of the most important bacterial strains>
• Determination of the Firmicutes/Bacteroidetes ratio
• Assessment of mucosaprotective flora
• Analysis of risk factors for dysbiosis-associated diseases

The test kit includes:

• 1 instruction for sample collection
• 1 Instruction for the report of the findings
• 1 sample accompanying form
• 1 guarantee certificate
• 1 sample tube incl. label in shipping container
• 1 microbiome sample tube with label in shipping container
• 1 stool catcher
• 1 shipping container
• 1 shipping bag

How does the ordering process work?

The link"To the article" will take you to the manufacturer's website where you can purchase the product. After you have placed your order, Medivere will send you the desired test package with detailed instructions. You put your sample into a tube and send it in a prepared envelope to Medivere's partner laboratory, GANZIMMUN DIAGNOSTICS AG. You will receive a report with the evaluation of your profile after about 14 working days.